Erratum to: HER2 Ile655Val polymorphism contributes to breast cancer risk: evidence from 27 case–control studies

Breast Cancer Research and Treatment, Oct 2010

Su Lu, Zhanwei Wang, Hong Liu, Xishan Hao

A PDF file should load here. If you do not see its contents the file may be temporarily unavailable at the journal website or you do not have a PDF plug-in installed and enabled in your browser.

Alternatively, you can download the file locally and open with any standalone PDF reader:

https://link.springer.com/content/pdf/10.1007%2Fs10549-010-1196-1.pdf

Erratum to: HER2 Ile655Val polymorphism contributes to breast cancer risk: evidence from 27 case–control studies

Breast Cancer Res Treat Erratum to: HER2 Ile655Val polymorphism contributes to breast cancer risk: evidence from 27 case-control studies Su Lu 0 1 2 3 4 Zhanwei Wang 0 1 2 3 4 Hong Liu 0 1 2 3 4 0 S. Lu H. Liu X. Hao Key Laboratory of Cancer prevention and Therapy , 30006 Tianjin , China 1 S. Lu H. Liu X. Hao (&) Key Laboratory of Breast Cancer Prevention and Therapy, Tianjin Medical University, Ministry of Education , 30006 Tianjin , China 2 Erratum to: Breast Cancer Res Treat 3 Z. Wang Department of Epidemiology and Biostatistics, Nanjing Medical University , 210029 Nanjing , China 4 S. Lu H. Liu (&) X. Hao Second Department of Breast Tumor, Tianjin Medical University Cancer Institute and Hospital , 300060 Tianjin , China Authors would like to add the following Acknowledgements: - (No. 2009GSI09). Acknowledgments This work is supported by the Innovation Funding for graduates of Tianjin Medical University, third phase of the 211 Project for Higher Education (...truncated)


This is a preview of a remote PDF: https://link.springer.com/content/pdf/10.1007%2Fs10549-010-1196-1.pdf

Su Lu, Zhanwei Wang, Hong Liu, Xishan Hao. Erratum to: HER2 Ile655Val polymorphism contributes to breast cancer risk: evidence from 27 case–control studies, Breast Cancer Research and Treatment, 2010, pp. 353-353, Volume 131, Issue 1, DOI: 10.1007/s10549-010-1196-1